Top Pharma Companies in India by Market Cap

BSE Sensex 74638.52 220.47 (-0.29%)

Filter

Top Pharma Companies in India as on Sep-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
61	Indoco Remedies Ltd.	Q V+ PT	2,302 Small Cap	257.35 (0.21%)	421.02	2.37	8.25	-199.84	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
62	Indraprastha Medical Corporation Ltd.	Q V PT	3,326 Small Cap	365.60 (-0.42%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
63	Innova Captab Ltd.	Q V PT	6,757 Small Cap	1,221.45 (2.00%)	43.84	6.04	31.75	26.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
64	IOL Chemicals And Pharmaceuticals Ltd.	Q V+ PT	5,957 Small Cap	202.65 (-0.25%)	35.47	3.2	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
65	Ipca Laboratories Ltd.	Q V+ PT	51,020 Mid Cap	2,005 (-0.15%)	40.96	6.1	7.35	1.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
66	Jagsonpal Pharmaceuticals Ltd.	Q V+ PT	1,504 Small Cap	227.65 (0.26%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
67	Jubilant Pharmova Ltd.	Q V+ PT	16,998 Small Cap	1,055.55 (0.58%)	47.47	2.34	6.31	-7.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
68	Jupiter Life Line Hospitals Ltd.	Q V PT	9,184 Small Cap	277.90 (0.69%)	48.23	5.72	25.27	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
69	Kilitch Drugs (India) Ltd.	Q V PT	678 Small Cap	213.20 (5.00%)	23.62	2.52	28.00	58.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
70	KMC Speciality Hospitals (India) Ltd.	Q V+ PT	2,453 Small Cap	161.25 (0.50%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
71	Kopran Ltd.	Q V+ PT	1,342 Small Cap	272.15 (-3.85%)	54.75	2.55	6.74	-8.11	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
72	Kovai Medical Center & Hospital Ltd.	Q V PT	6,820 Small Cap	6,117.50 (-0.90%)	26.35	4.87	18.09	25.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
73	Krishna Institute of Medical Sciences Ltd	Q V PT	34,063 Small Cap	795 (0.70%)	162.31	8.76	24.04	3.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
74	Krsnaa Diagnostics Ltd.	Q V PT	1,757 Small Cap	570.25 (2.71%)	18.48	1.82	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
75	Kwality Pharmaceuticals Ltd.	Q V+ PT	3,606 Small Cap	3,700 (-3.57%)	49.12	11.17	13.94	34.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
76	Laurus Labs Ltd.	Q V+ PT	1,05,645 Mid Cap	2,019 (0.05%)	99.72	19.34	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
77	Laxmi Dental Ltd.	Q V PT	1,087 Small Cap	192.80 (-0.98%)	34.69	4.24	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
78	Lincoln Pharmaceuticals Ltd.	Q V PT	1,215 Small Cap	602.55 (-0.53%)	12.58	1.53	10.03	10.09	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
79	Lupin Ltd.	Q V PT	98,070 Mid Cap	2,122.95 (0.14%)	17.53	4.07	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
80	Mankind Pharma Ltd.	Q V PT	95,744 Mid Cap	2,463.50 (1.38%)	49.13	5.96	18.10	8.40	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
81	Marksans Pharma Ltd.	Q V+ PT	14,492 Small Cap	332.85 (-1.57%)	29.65	4.82	16.48	7.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
82	Max Healthcare Institute Ltd.	Q V PT	1,02,684 Mid Cap	1,066.05 (0.15%)	71.11	9.48	27.27	155.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
83	Medicamen Biotech Ltd.	Q V+ PT	448 Small Cap	328.95 (4.63%)	39.38	1.58	5.31	-13.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
84	Medico Remedies Ltd.	Q V PT	291 Small Cap	33.90 (-0.59%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
85	Metropolis Healthcare Ltd.	Q V PT	12,396 Small Cap	595.75 (0.18%)	61.19	7.91	10.52	0.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
86	Morepen Laboratories Ltd.	Q V+ PT	6,625 Small Cap	119.65 (-2.21%)	47.71	5.15	8.73	-11.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
87	Narayana Hrudayalaya Ltd.	Q V PT	39,437 Mid Cap	1,906 (0.51%)	47.49	8.16	25.04	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
88	Natco Pharma Ltd.	Q V+ PT	14,578 Small Cap	815.70 (-0.10%)	12.78	1.57	14.72	28.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
89	Nephrocare Health Services Ltd.	Q V+ PT	7,478 Small Cap	753.60 (0.28%)	98.35	6.66	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
90	Neuland Laboratories Ltd.	Q V+ PT	29,349 Small Cap	22,740 (0.62%)	58.25	14.35	16.64	37.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anlon Healthcare	28.97	9.73%
Ind-Swift Labs.	409.95	7.44%
Aarti Pharmalabs	893	5.50%
Shukra Pharmaceut.	58.14	5.25%
Kilitch Drugs(India)	213.20	5%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Guj. Kidney & Super	175.95	-3.93%
Kopran	272.15	-3.85%
Kwality Pharma	3,700	-3.57%
Acutaas Chemicals	3,312.70	-3.20%
Concord Biotech	1,544.65	-2.28%

News about Top Pharma Companies in India

Sep, 2026

Krsnaa Diagnostics informs about updates

Krsnaa Diagnostics has informed regarding the voting results as the outcome of the postal ballot dated September 17, 2026.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Krsnaa Diagnostics informs about voting results of postal ballot and scrutinizer report

With reference to its letter no. KDL/SE/032/2026-27 dated August 18, 2026, Krsnaa Diagnostics has informed that it enclosed the Postal Ballot Notice dated August 13, 2026 (‘Notice’) for seeking approval of the shareholders of the Company on special resolution: Approval for Issuance of up to 16,21,000 Warrants Convertible into Equity Shares of Face Value Rs.5/- each on a Preferential Basis to the Promoter and Promoter Group of the Company. Pursuant to Sections 108, 110 and other applicable provisions, if any, of the Companies Act, 2013 (‘the Act’) read with the Companies (Management and Administration) Rules, 2014, guidelines prescribed by the Ministry of Corporate Affairs through various Circular(s) and the Listing Regulations, as amended from time to time, the Postal Ballot was conducted through remote e-voting process. The remote e-voting process concluded on Thursday, September 17, 2026, at 17:00 Hrs. (IST), post which Dinesh Shivnarayan Birla (Membership No.: FCS-7658, COP: 13029), Practicing Company Secretary and Proprietor of Dinesh Birla & Associates, Company Secretaries, Scrutinizer submitted the Report on the Postal Ballot voting results on September 18, 2026. Based on the Scrutinizer’s Report, the company has informed that the Special Resolution mentioned in the Postal Ballot Notice dated August 13, 2026 has been passed by the Members of the Company with requisite majority on September 17, 2026, i.e., the last date of remote e-voting. In connection with the above, it has enclosed the following: a. Voting results pursuant to Regulation 44(3) of the Listing Regulations and Section 108 of the Act read with the Companies (Management and Administration) Rules, 2014; and b. Scrutinizer's Report dated September 18, 2026 on remote e-voting.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Indoco Remedies gets nod to incorporate wholly owned subsidiary

The committee of executive directors of the company in its meeting held on September 18, 2026 has considered and approved the same

Sep, 2026

Kovai Medical Center and Hospital informs about closure of trading window

Pursuant to Clause 4 of Schedule B of SEBI (Prohibition of Insider Trading) Regulations 2015, as amended and the Company's Code of Conduct for Prevention of Insider Trading, Kovai Medical Center and Hospital has informed that the Trading Window for trading in Company's Securities shall remain closed from 1st October 2026 till the end of 48 hours after the declaration of Un-audited Financial Results for the Quarter / Half year ended 30th September 2026 for insiders, designated persons and their immediate relatives. The date of Board Meeting for declaration of Un-audited Financial Results or the Company for the Quarter / Half year ended 30th September, 2026 will be intimated in due course.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Indoco Remedies informs about outcome of AGM

Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has submitted the details regarding the proceedings of the 79th Annual General Meeting (AGM) of the Company held on Thursday, 17th September, 2026 at 10:30 am through Video Conferencing (VC) / Other Audio Video Means (OAVM).

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Krishna Institute of Medical Sciences submit analyst meet intimation

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krishna Institute of Medical Sciences has informed that the details of the proposed schedule of the Analyst/ Institutional Investor Meeting on September 21, 2026.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	3B Blackbio Dx Ltd.	1,139 Crore
2	Aarti Drugs Ltd.	3,941 Crore
3	Aarti Pharmalabs Ltd.	7,443 Crore
4	Abbott India Ltd.	57,954 Crore
5	Acutaas Chemicals Ltd.	28,149 Crore
6	Advanced Enzyme Technologies Ltd.	3,227 Crore
7	Ajanta Pharma Ltd.	44,562 Crore
8	Akums Drugs & Pharmaceuticals Ltd.	12,339 Crore
9	Alembic Pharmaceuticals Ltd.	16,623 Crore
10	Alivus Life Sciences Ltd.	17,570 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,959	1,82,738	83.79	20.36	38.34	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	27.89
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,019	1,05,645	117
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	76.91
Aurobindo Pharma Ltd. (M)	Very Good	1,696	99,828	53.55
Divis Laboratories Ltd. (L)	Very Good	9,405	2,48,664	52.16
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	45.50
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	23.61
Mankind Pharma Ltd. (M)	Very Good	2,464	95,744	46.87	5.69	24.40	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,172	1,15,012	25.48	4.27	14.28	13.52
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	43.30	4.60	22.09	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	39.96
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	22.19
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,214	97,749	30.34	2.56	15.56	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Krsnaa Diagnostics informs about updates

Krsnaa Diagnostics informs about voting results of postal ballot and scrutinizer report

Indoco Remedies gets nod to incorporate wholly owned subsidiary

Kovai Medical Center and Hospital informs about closure of trading window

Indoco Remedies informs about outcome of AGM

Krishna Institute of Medical Sciences submit analyst meet intimation

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?